Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    8035251 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
Conditions: Cancer;   Anorexia;   Taste Disorders;   Olfactory Disorders
Interventions: Drug: Marinol (Dronabinol);   Other: Placebo

Indicates status has not been verified in more than two years